In Flemingsberg, we cure diseases that were previously considered incurable

Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.

”It’s fantastic, it’s a great opportunity to learn more about what’s going on at Karolinska and for the whole ATMP environment. From the Pre GMP to the manufacturing, to then the clinical trials that they offer here, and I think that’s one of the things that are really unique about the whole Flemingsberg ATMP ecosystem” – Jonathan Clarke, Development Manager at SmartCella.

During the event we launched ATMP Flemingsberg, a platform that encapsulates all the expertise within ATMP in Flemingsberg, from research to clinical implementation.

”We have everything in Flemingsberg and you can see that because they come here from Uppsala and other parts of the world to manufacture their products and do their treatments here” – Ewa Ellis, ATMP coordinator at Karolinska University Hospital.

The seminar shed light on Pre-GMP and GMP, as well as how to advance one’s process to the next level and how Vecura can assist in scaling up. Additionally, Stefan Mielke, an expert in the field, discussed equal access and emphasized the importance of collaborative efforts to make therapies more accessible to patients. Di Yu from Elicera Therapeutics also shared their journey, which began at Vecura in Flemingsberg.

“Clinical trials are very important because they bring innovation to our patients. For those of you who don’t know what CAR-T cells are, they are like glasses for T-cells, so that they can see tumor cells.” – Stephan Mielke, Professor and Scientific Director of the Cancer Center.

Watch our film below, summarizing our successful event. Together, we can accelerate access to ATMPs in the Nordics.

Visit atmpflemingsberg.se

*ATMP (Advanced Therapy Medicinal Products) också kallade Avancerade terapiläkemedel är baserade på celler, vävnader eller gener och delas in i tre huvudkategorier: somatiska cellterapier, genterapier och vävnadstekniska produkter.

How Do You Build a Place Where More Organizations Want to Establish Themselves?

What is it that actually makes a company, research environment or organization choose to establish itself in a particular place? It is rarely just about premises or geography. Just as important are access to talent, networks, collaboration and a shared direction for the future. In Flemingsberg, a number of stakeholders are working together through Etableringskontor Flemingsberg to strengthen the area’s attractiveness and create the best possible conditions for future establishments. Pernilla Boström tells us more about the work, the goals and what we took away from a study visit to Lund and Malmö.

New incubator in Flemingsberg to strengthen cultural and creative ideas with support from across Europe

I höst startar H&ART Incubator vid Södertörns högskola, en ny satsning för personer med idéer inom konst, kulturarv och kulturella och kreativa näringar. Inkubatorn är en del av ett europeiskt nätverk med elva universitet i elva länder och ger deltagarna tillgång till både lokalt stöd och ett internationellt nätverk av mentorer, experter och samarbetspartners.

HackNation Comes to Flemingsberg: Strengthening the Connection Between Stockholm and Silicon Valley

A global innovation network with roots in MIT and Silicon Valley is coming to Flemingsberg. On October 3-4, students, researchers, entrepreneurs and developers will gather at Innovation Station to build solutions alongside participants from more than 65 countries. The initiative is led by the GameTech initiative Press Start and the life science initiative Life Science Cluster Flemingsberg, with the ambition of creating new bridges between Stockholm, Silicon Valley and some of the world's leading innovation ecosystems.

12 Next